Sinew Pharma Inc. (TPEX: 6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
46.40
-0.60 (-1.28%)
Dec 20, 2024, 1:31 PM CST
-33.04%
Market Cap 3.31B
Revenue (ttm) n/a
Net Income (ttm) -178.48M
Shares Out 71.33M
EPS (ttm) -2.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,632
Open 46.90
Previous Close 47.00
Day's Range 45.35 - 47.00
52-Week Range 43.85 - 80.90
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 20, 2025

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630, a pre-clinical drug for treating patients with non-alcoholic steatohepatitis. It is also developing SNP-810 for use in analgesic and antipyretic indications; and SNP-830 and SNP-840, which are used as hepatotoxicit... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.